Silo Pharma Invests in ResearchCoin, Diversifying Digital Asset Portfolio

US-listed company Silo Pharma has made an unexpected move into the world of altcoins by acquiring ResearchCoin (RSC). This acquisition aligns with their broader digital asset strategy, aimed at capturing long-term value from various blockchain opportunities. Silo Pharma specializes in biopharmaceutical and cryptocurrency treasury management. The company’s investment in RSC marks a significant step towards diversifying their portfolio and supporting the growth of decentralized scientific research via ResearchHub, a platform spearheaded by Coinbase CEO Brian Armstrong.